Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
License and other revenues $ 3,500 $ 1,414
Expenses:    
Royalties 1,605 450
Research and development 31,091 28,965
General and administrative 19,004 17,256
Impairment of licensed technology 1,355
Loss/(gain) on operating lease right-of-use assets (1,065) 2,511
Impairment of construction-in-progress 1,792
Total expenses 50,635 52,329
Loss from operations (47,135) (50,915)
Interest income 2,117 431
Interest expense (418) (736)
Change in fair value of warrant liabilities (11,695) 11,383
Other income 2,943 141
Net loss (54,188) (39,696)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock (3,782)
Net loss attributable to Common Shareholders $ (54,188) $ (43,478)
Loss per common share - basic $ (2.53) $ (5.53)
Loss per common share - diluted $ (2.53) $ (5.53)
Weighted average number of common shares outstanding - basic 21,380,476 7,861,515
Weighted average number of common shares outstanding - diluted 21,380,476 7,861,515
Other comprehensive income (loss):    
Change in unrealized gains (losses) related to available-for-sale debt securities $ 34 $ (99)
Foreign currency translation adjustments 29 (3)
Comprehensive loss $ (54,125) $ (43,580)